Stay updated with breaking news from Immunization Act. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
A return to trays of glistening tandoori and hand-rolled naan for the first time since the start of the Covid-19 pandemic is a return to normalcy
The Mainichi Shimbun answers some common questions readers may have about Japan's low coronavirus vaccination rate compared to some other countries.
COVID-19 Vaccination Fukuoka City has announced that it is starting its vaccination program for a portion of elderly residents from April 12. It is expected that all elderly residents will receive a notice and voucher for vaccination from the city later this month. Who can get a vaccine? Anyone aged16 and above, including non-Japanese residents. However, the government is administering vaccines in the following order: 1) health care professionals and others who provide medical treatment for COVID-19 patients and others directly; 2) persons aged 65 and above; and 3) staff who interact directly...
Dec 30, 2020 New, potentially more infectious variants of the novel coronavirus that surfaced in the U.K. and South Africa have been detected in Japan over the past week, raising alarm that this could further accelerate the spread of the virus and cast a shadow over the economic recovery, let alone the hosting of the Tokyo Games slated for next year. What do we know about the new variants and what are the overall ramifications, including whether the vaccines are effective against them? Mutations The new variant, originally found in mid-September in the southeast of the U.K., has doze...
news Editorial: Japan vaccine rollout should prioritize safety, address fears The Mainichi © The Mainichi Screening of new coronavirus vaccines has begun in Japan, with American firm Pfizer Inc. applying to the Ministry of Health, Labor and Welfare for special approval of the vaccine it developed. A number of countries have already green-lit use of Pfizer's vaccine, and vaccinations have started in the U.S., U.K. and elsewhere. But the normal procedures have been truncated, leaving open the possibility of unexpected side effects. Tests in this country should go ahead with sa...